Taigo Kato

3.2k total citations
118 papers, 1.6k citations indexed

About

Taigo Kato is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Taigo Kato has authored 118 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Oncology, 44 papers in Pulmonary and Respiratory Medicine and 33 papers in Surgery. Recurrent topics in Taigo Kato's work include Cancer Immunotherapy and Biomarkers (28 papers), Renal cell carcinoma treatment (26 papers) and Bladder and Urothelial Cancer Treatments (19 papers). Taigo Kato is often cited by papers focused on Cancer Immunotherapy and Biomarkers (28 papers), Renal cell carcinoma treatment (26 papers) and Bladder and Urothelial Cancer Treatments (19 papers). Taigo Kato collaborates with scholars based in Japan, United States and Germany. Taigo Kato's co-authors include Norio Nonomura, Jae‐Hyun Park, Yusuke Nakamura, Kazuma Kiyotani, Motohide Uemura, Ryoichi Imamura, Atsunari Kawashima, Yuji Ikeda, Koji Hatano and Kazutoshi Fujita and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Taigo Kato

112 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Taigo Kato Japan	27	633	547	402	326	307	118	1.6k
Per Lindnér Sweden	23	661 1.0×	472 0.9×	333 0.8×	308 0.9×	170 0.6×	80	1.6k
Masahiro Ohira Japan	22	572 0.9×	415 0.8×	561 1.4×	491 1.5×	306 1.0×	185	2.0k
Dirk Behringer Germany	27	1.1k 1.7×	630 1.2×	424 1.1×	181 0.6×	388 1.3×	69	2.2k
Ali Amirkhosravi United States	27	720 1.1×	685 1.3×	516 1.3×	274 0.8×	253 0.8×	62	2.5k
Katrina Wood United Kingdom	23	703 1.1×	699 1.3×	770 1.9×	155 0.5×	284 0.9×	61	2.4k
Michiyoshi Hisanaga Japan	22	632 1.0×	439 0.8×	212 0.5×	691 2.1×	213 0.7×	55	1.7k
Lucía López‐Corral Spain	28	699 1.1×	934 1.7×	289 0.7×	114 0.3×	72 0.2×	91	2.2k
Yubin Kang United States	24	614 1.0×	748 1.4×	459 1.1×	133 0.4×	269 0.9×	97	1.9k
Michail Doukas Netherlands	18	784 1.2×	279 0.5×	363 0.9×	521 1.6×	344 1.1×	108	1.6k
Laurent Doucet France	19	159 0.3×	285 0.5×	142 0.4×	202 0.6×	385 1.3×	49	975

Countries citing papers authored by Taigo Kato

Since Specialization

Citations

This map shows the geographic impact of Taigo Kato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taigo Kato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taigo Kato more than expected).

Fields of papers citing papers by Taigo Kato

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Taigo Kato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taigo Kato. The network helps show where Taigo Kato may publish in the future.

Co-authorship network of co-authors of Taigo Kato

This figure shows the co-authorship network connecting the top 25 collaborators of Taigo Kato. A scholar is included among the top collaborators of Taigo Kato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taigo Kato. Taigo Kato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ishihara, Hiroki, et al.. (2025). Translational Research Bridging Basic and Clinical Insights in Renal Cell Carcinoma: A Collaborative Review and Future Directions. International Journal of Urology. 32(8). 932–943. 1 indexed citations

Hansmann, Leo, Guoshuai Cao, Jun Huang, et al.. (2025). Selection of therapeutically effective T-cell receptors from the diverse tumor-bearing repertoire. Journal for ImmunoTherapy of Cancer. 13(5). e011351–e011351. 2 indexed citations

Kitagawa, A., Akira Nishio, Hayato Hikita, et al.. (2025). A rare case of a malignant hepatic perivascular epithelioid cell tumor (PEComa) with aggressive progression following the relapse of renal pecoma despite everolimus therapy. Clinical Journal of Gastroenterology. 18(2). 343–351.

Kato, Taigo, Junya Furukawa, Nobuyuki Hinata, et al.. (2024). Real-world outcomes of avelumab plus axitinib in patients with advanced renal cell carcinoma in Japan: long-term follow-up from the J-DART2 retrospective study. International Journal of Clinical Oncology. 30(1). 99–109. 2 indexed citations

Kawashima, Atsunari, Yu Ishizuya, Yoshiyuki Yamamoto, et al.. (2024). Recent developments and future directions of first-line systemic therapy combined with immunotherapy for advanced or metastatic urothelial carcinoma: a historical perspective on treatment evolution. International Journal of Clinical Oncology. 29(8). 1096–1104. 4 indexed citations

Kato, Taigo, et al.. (2024). Efficacy of Magnesium Supplementation in Cancer Patients Developing Hypomagnesemia Due to Anti-EGFR Antibody: A Systematic Review. Cancer Diagnosis & Prognosis. 4(4). 390–395. 2 indexed citations

Yamanaka, Kazuaki, Taigo Kato, Koji Hatano, et al.. (2024). A retroperitoneal primary undifferentiated pleomorphic sarcoma. Urology Case Reports. 53. 102664–102664. 3 indexed citations

Yamamichi, Gaku, Taigo Kato, Noriaki Arakawa, et al.. (2024). GDF15 propeptide promotes bone metastasis of castration-resistant prostate cancer by augmenting the bone microenvironment. Biomarker Research. 12(1). 147–147. 3 indexed citations

Shiota, Masaki, Nobuaki Matsubara, Taigo Kato, et al.. (2024). Genomic profiling and clinical utility of circulating tumor DNA in metastatic prostate cancer: SCRUM-Japan MONSTAR SCREEN project. PubMed. 2(1). 28–28. 1 indexed citations

10.

Nagahara, Akira, Yu Ishizuya, Yoshiyuki Yamamoto, et al.. (2024). The prognostic impact of peripheral blood eosinophil counts in metastatic renal cell carcinoma patients treated with nivolumab. Clinical and Experimental Medicine. 24(1). 111–111. 1 indexed citations

11.

Jingushi, Kentaro, Atsunari Kawashima, Takuro Saito, et al.. (2024). Cutibacterium acnes‐derived extracellular vesicles promote tumor growth in renal cell carcinoma. Cancer Science. 115(8). 2578–2587. 13 indexed citations

12.

Yamamoto, Yoshiyuki, Taigo Kato, Koji Hatano, et al.. (2023). A case of retroperitoneal liposarcoma extending through the inguinal canal to the thigh and lesser trochanter. IJU Case Reports. 6(4). 257–261. 1 indexed citations

13.

Jingushi, Kentaro, Atsunari Kawashima, Takuro Saito, et al.. (2022). Circulating extracellular vesicles carrying Firmicutes reflective of the local immune status may predict clinical response to pembrolizumab in urothelial carcinoma patients. Cancer Immunology Immunotherapy. 71(12). 2999–3011. 10 indexed citations

14.

Hatano, Koji, Akinaru Yamamoto, Toshihiro Uemura, et al.. (2022). The presence of lymph node metastases and time to castration resistance predict the therapeutic effect of enzalutamide for castration-resistant prostate cancer. International Journal of Clinical Oncology. 28(3). 427–435. 2 indexed citations

15.

Kato, Taigo, Masataka Kawamura, Shigeaki Nakazawa, et al.. (2020). <p>Clinical Efficacy of Intravenous Immunoglobulin for BK Polyomavirus-Associated Nephropathy After Living Kidney Transplantation</p>. Therapeutics and Clinical Risk Management. Volume 16. 947–952. 10 indexed citations

16.

Matsuda, Tatsuo, Matthias Leisegang, Jae‐Hyun Park, et al.. (2018). Induction of Neoantigen-Specific Cytotoxic T Cells and Construction of T-cell Receptor–Engineered T Cells for Ovarian Cancer. Clinical Cancer Research. 24(21). 5357–5367. 67 indexed citations

17.

Zewde, Makda, Kazuma Kiyotani, Jae‐Hyun Park, et al.. (2018). The era of immunogenomics/immunopharmacogenomics. Journal of Human Genetics. 63(8). 865–875. 10 indexed citations

18.

Ikeda, Yuji, Jae‐Hyun Park, Takashi Miyamoto, et al.. (2016). T-LAK Cell-Originated Protein Kinase (TOPK) as a Prognostic Factor and a Potential Therapeutic Target in Ovarian Cancer. Clinical Cancer Research. 22(24). 6110–6117. 64 indexed citations

19.

Yamanaka, Kazuaki, Yoichi Kakuta, Shigeaki Nakazawa, et al.. (2016). Induction Immunosuppressive Therapy With Everolimus and Low-Dose Tacrolimus Extended-Release Preserves Good Renal Function at 1 Year After Kidney Transplantation. Transplantation Proceedings. 48(3). 781–785. 4 indexed citations

20.

Ikeda, Yuji, Kazuma Kiyotani, Poh Yin Yew, et al.. (2015). Germline PARP4 mutations in patients with primary thyroid and breast cancers. Endocrine Related Cancer. 23(3). 171–179. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact